摘要:血管内皮生长因子(VEGF)的单克隆抗体Avastin是一种新的靶向治疗药物,可抑制肿瘤新生血管生成。国外研究显示,Avastin与一些化疗方案合用可进一步提高转移性结直肠癌患者的疗效。我们将Avastin+FOLFOX4[奥沙利铂+氟尿嘧啶(5-Fu)/醛氢叶酸(LV)]方案有效治疗经多种化疗方案治疗后复发转移性结肠癌一例的结果报道如下。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Earthquake Engineering and Engineering Vibration Journal of Integrative Agriculture Advances in Atmospheric Sciences Chemical Research in Chinese Universities Journal of Integrative Plant Biology Chinese Journal of Integrative Medicine Journal of Central South University Journal of Zhejiang University Science A Applied Mathematics:A Journal of Chinese Universities